Xiao-Dong Wang1, Ying-Liang Wang1, Wen-Feng Gao2. 1. Department of Immunology and Rheumatology, Affiliated Hospital of Weifang Medical University Weifang 261031, Shandong, China. 2. Department of Immunology and Rheumatology, Clinical Faculty (Affiliated Hospital), Weifang Medical University Weifang 261053, Shandong, China.
Abstract
OBJECTIVE: To observe the anti-inflammatory effects of honokiol in primary cultures of peripheral blood mononuclear cells of rheumatoid arthritis patients, the pro-inflammatory cytokines and potential targets were investigated. METHODS: The levels of GM-CSF, IL-1β, TNF-α and IL-8 were determined by ELISA assay. The genes and proteins expression were analyzed by real-time PCR and Western blotting respectively. RESULTS: The serum IL-1β, TNF-α and GM-CSF levels were 1.76-, 2.16- and 3.57-fold increased in patients with RA as compared to those of control group. Honokiol inhibited the expression levels of IL-1β, TNF-α, GM-CSF and IL-8 in PBMCs with a dose-dependent manner. Measurements obtained from supernatants were positively correlated between TNF-α and IL-1β, moreover, similar results found TNF-α levels positively correlated with GM-CSF and IL-8 activity in the supernatants of PBMCs isolated from RA patients. Furthermore, the mRNA and protein expression of IL-1β, GM-CSF and IL-8 were up-regulated when the PBMCs exposure to TNF-α, however, honokiol treatment significantly reversed the expression of IL-1β, TNF-α and GM-CSF in response to TNF-α with a dose-dependent manner. CONCLUSIONS: This study demonstrates that honokiol could possess potential anti-inflammatory effects and inhibits TNF-α-induced IL-1β, GM-CSF and IL-8 production in PBMCs from rheumatoid arthritis patients.
OBJECTIVE: To observe the anti-inflammatory effects of honokiol in primary cultures of peripheral blood mononuclear cells of rheumatoid arthritispatients, the pro-inflammatory cytokines and potential targets were investigated. METHODS: The levels of GM-CSF, IL-1β, TNF-α and IL-8 were determined by ELISA assay. The genes and proteins expression were analyzed by real-time PCR and Western blotting respectively. RESULTS: The serum IL-1β, TNF-α and GM-CSF levels were 1.76-, 2.16- and 3.57-fold increased in patients with RA as compared to those of control group. Honokiol inhibited the expression levels of IL-1β, TNF-α, GM-CSF and IL-8 in PBMCs with a dose-dependent manner. Measurements obtained from supernatants were positively correlated between TNF-α and IL-1β, moreover, similar results found TNF-α levels positively correlated with GM-CSF and IL-8 activity in the supernatants of PBMCs isolated from RA patients. Furthermore, the mRNA and protein expression of IL-1β, GM-CSF and IL-8 were up-regulated when the PBMCs exposure to TNF-α, however, honokiol treatment significantly reversed the expression of IL-1β, TNF-α and GM-CSF in response to TNF-α with a dose-dependent manner. CONCLUSIONS: This study demonstrates that honokiol could possess potential anti-inflammatory effects and inhibits TNF-α-induced IL-1β, GM-CSF and IL-8 production in PBMCs from rheumatoid arthritispatients.
Authors: J J Haringman; D M Gerlag; A H Zwinderman; T J M Smeets; M C Kraan; D Baeten; I B McInnes; B Bresnihan; P P Tak Journal: Ann Rheum Dis Date: 2004-12-02 Impact factor: 19.103
Authors: K M Hummel; P K Petrow; J K Franz; U Müller-Ladner; W K Aicher; R E Gay; D Brömme; S Gay Journal: J Rheumatol Date: 1998-10 Impact factor: 4.666
Authors: Amy E Solinski; Cristian Ochoa; Young Eun Lee; Thomas Paniak; Marisa C Kozlowski; William M Wuest Journal: ACS Infect Dis Date: 2017-12-13 Impact factor: 5.084
Authors: Nathan J Klingensmith; Ching-Wen Chen; Zhe Liang; Eileen M Burd; Alton B Farris; Jack L Arbiser; Mandy L Ford; Craig M Coopersmith Journal: Shock Date: 2018-08 Impact factor: 3.454
Authors: Sidra Khalid; Muhammad Z Ullah; Ashraf U Khan; Ruqayya Afridi; Hina Rasheed; Adnan Khan; Hussain Ali; Yeong S Kim; Salman Khan Journal: Front Pharmacol Date: 2018-03-20 Impact factor: 5.810